Fig. 3From: Efficacy of two siddha polyherbal decoctions, Nilavembu Kudineer and Kaba Sura Kudineer, along with standard allopathy treatment in the management of mild to moderate symptomatic COVID-19 patients—a double-blind, placebo-controlled, clinical trialSubject disposition displaying screening and treatment allocation of participants. A total 125 patients were enrolled, and 5 patients withdrew from study. Out of 120 patients, all were equally allotted into 3 groups each 40. In that 40, further divided 3:1 ratio for mild and moderate cases (based on ICMR, Min. of Health COVID-19 Criteria). Here, male/female patients were also equally distributed to all three groups. Randomization done by simple stratified randomizationBack to article page